New Paper "Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas"
Mirco Friedrich, Roman Sankowski, Lukas Bunse and colleagues from the University of Freiburg and the German Cancer Research Center (DKFZ), have published a new manuscript about the influence of Tryptophan metabolism on IDH-mutant gliomas. Congratulations and thanks for using Galaxy!
The dynamics and phenotypes of intratumoral myeloid cells during tumor progression are poorly understood. Here we define myeloid cellular states in gliomas by longitudinal single-cell profiling and demonstrate their strict control by the tumor genotype: in isocitrate dehydrogenase (IDH)-mutant tumors, differentiation of infiltrating myeloid cells is blocked, resulting in an immature phenotype. In late-stage gliomas, monocyte-derived macrophages drive tolerogenic alignment of the microenvironment, thus preventing T cell response. We define the IDH-dependent tumor education of infiltrating macrophages to be causally related to a complex re-orchestration of tryptophan metabolism, resulting in activation of the aryl hydrocarbon receptor. We further show that the altered metabolism of IDH-mutant gliomas maintains this axis in bystander cells and that pharmacological inhibition of tryptophan metabolism can reverse immunosuppression. In conclusion, we provide evidence of a glioma genotype-dependent intratumoral network of resident and recruited myeloid cells and identify tryptophan metabolism as a target for immunotherapy of IDH-mutant tumors.
Finally out! We are thrilled to share our new paper on education of immunosuppressive myeloid cells in IDH-mutant glioma which was published today in @NatureCancer 🎉 A huge thank you to our fantastic collaborators 🙏 Check it out 👇https://t.co/NO4wnRFRTH pic.twitter.com/qOg4h35PFA— The Platten Lab (@Platten_lab) May 24, 2021